** Shares of surgical implants maker Paragon 28 FNA.N rise ~9.5% to $13.14 premarket
** Medical device maker Zimmer Biomet ZBH.N said late on Tuesday it will acquire Paragon 28 for about $1.1 billion
** The deal will give Zimmer access to Paragon's surgical implants and equipment used to treat foot and ankle ailments
** Brokerage Truist says the deal makes "strategic sense" for Zimmer as "foot and ankle" is a faster growing subsegment of the orthopedic market
** Zimmer will make an upfront payment of $13.00/shr in cash, which represents an 8.3% premium to Paragon's closing price on Tuesday
** Up to last close, stock down 2.3% in the last 12 months
(Reporting by Christy Santhosh)
((Christy.Santhosh@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.